announcement

    Electrome Provides Update on the ActiPatch® Provider Program

    Provider program enrollment and clinical operations milestones for the ActiPatch® experience.

    AP
    ActiPatch® Press Desk
    Newsroom
    January 20, 2026 2 min read
    Electrome Provides Update on the ActiPatch® Provider Program

    Electrome Corporation today provided an update on the PAINKILLER provider program. The program continues to add provider organizations across the company's access, clinical, and outcomes program lines, and clinical operations milestones are on plan.

    Update scope

    Provider onboarding, clinical workspace deployment, RTM workflow integration, and outcomes reporting are operating at the cadence the company committed to at launch. Specific organization names are disclosed only when partners authorize disclosure.

    About the program

    The Electrome provider program supports clinicians and clinical organizations adopting the FDA cleared pulsed shortwave therapy device behind PAINKILLER as part of their chronic pain workflow. The program includes clinician facing collateral, integration with existing chart workflows, structured patient onboarding, and a longitudinal data view that supports follow up visits without adding documentation burden. Provider organization names are disclosed only when those partners authorize disclosure.

    Why provider integration matters

    Bioelectric therapy reaches its full clinical value when it is part of a coordinated chronic pain plan rather than a stand alone purchase. Provider integration is the channel through which that coordination happens. The program is built to make adoption straightforward for clinicians and to make the resulting care meaningfully better for the patient, with adherence and outcomes capture supporting the value based care frameworks that increasingly shape how chronic pain is reimbursed.

    About Electrome Corporation

    Electrome Corporation operates the bioelectric medicine platform behind PAINKILLER and a portfolio of coordinated channels across direct to consumer, provider, retailer, affiliate, and research relationships. The provider program is one of those channels and is part of how the FDA cleared device reaches the patients who benefit from it inside a real clinical relationship.

    About provider onboarding

    Provider onboarding is structured to fit the operational reality of a busy pain practice. Onboarding includes the clinical reference material, the workflow integration with the platform's clinician surface, the patient enrollment path, and the ongoing reporting that supports the clinic's quality measurement work. The Electrome platform supports the provider relationship after onboarding with shared longitudinal data on adherence and outcomes, so the clinical decision making around the bioelectric component is informed rather than blind.

    AP
    ActiPatch® Press Desk
    Newsroom, Electrome